Chia genome sequenced, revealing potential health benefits

In a recent study published in Frontiers in Plant Science, researchers presented the assembly of the chia reference genome.

Roivant autoimmune drug succeeds in Phase 2 study in eye condition

A drug being developed by a Roivant subsidiary for a range of autoimmune conditions succeeded in a mid-stage trial in an eye disease that can

April 2, 2024

Success With HIV-to-HIV Kidney Transplants

Three people living with HIV had promising outcomes after donating kidneys to three others with HIV, according to a prospective study within the HOPE in

August 1, 2023

EyeBio doubles the size of its Series A as anti-VEGF veterans seek new ways of treating retinal diseases

Retinal disease biotech EyeBio has doubled the size of its initial Series A raise from February 2022. With another $65 million, the biotech will further

November 15, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.